Novel caffeine-based compounds exhibit potential prevention strategy for Parkinson’s disease
Researchers from the University of Saskatchewan (Saskatoon, Canada) have potentially identified two caffeine-based compounds that have displayed the ability to prevent the effects of Parkinson’s disease.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.